Secukinumab-induced Raynaud's phenomenon: first report in the literature

被引：6
|
作者：
Kobak, Senol [1 ]
机构：
[1] Istinye Univ, Fac Med, LIV Hosp, Dept Rheumatol, Canan Sokak 5, TR-34340 Ulus Istanbul, Turkey
来源：
THERAPEUTIC ADVANCES IN DRUG SAFETY | 2020年 / 11卷
关键词：
ankylosing spondylitis; Raynaud's phenomenon; secukinumab; DISEASE; DRUGS;
D O I：
10.1177/2042098620905976
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Secukinumab is an IL-17A antagonist that has proven efficacy in the treatment of patients with ankylosing spondylitis (AS) and psoriatic arthritis. Side effects of the drug include infections, skin rashes, and allergic reactions. Raynaud's phenomenon (RP), a vasospastic syndrome and an important feature of different connective tissue diseases, is not an expected finding in AS patients. This article reports the development of secukinumab-related RP in a 35-year-old female patient with AS. Treatment with secukinumab was continued and RP was treated with low-dose aspirin and a calcium-channel blocker.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Raynaud's Phenomenon in a Slap Bass Player A Case Report
    Jepsen, Jorgen Riis
    Simonsen, Jane Angel
    MEDICAL PROBLEMS OF PERFORMING ARTISTS, 2016, 31 (01) : 51 - 53
  • [32] First report of a vincristine dose-related Raynaud's phenomenon in an adolescent with malignant brain tumor
    Gottschling, S
    Meyer, S
    Reinhard, H
    Krenn, T
    Graf, N
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2004, 26 (11) : 768 - 769
  • [33] Ischemic Pain in the Extremities and Raynaud's Phenomenon
    Devulder, Jacques
    van Suijlekom, Hans
    van Dongen, Robert
    Diwan, Sudhir
    Mekhail, Nagy
    van Kleef, Maarten
    Huygen, Frank
    PAIN PRACTICE, 2011, 11 (05) : 483 - 491
  • [34] Treatment of Raynaud's phenomenon
    Garcia-Carrasco, Mario
    Jimenez-Hernandez, Mario
    Escarcega, Ricardo O.
    Mendoza-Pinto, Claudia
    Pardo-Santos, Rodrigo
    Levy, Roger
    Maldonado, Claudio Galarza
    Perez Chavez, Gonzalo
    Cervera, Ricard
    AUTOIMMUNITY REVIEWS, 2008, 8 (01) : 62 - 68
  • [35] Pathogenesis of Raynaud's phenomenon
    Herrick, AL
    RHEUMATOLOGY, 2005, 44 (05) : 587 - 596
  • [36] y Raynaud's phenomenon
    Herrick, Ariane L.
    Wigley, Fredrick M.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2020, 34 (01):
  • [37] Raynaud's phenomenon in children
    Quartier, P
    ARCHIVES DE PEDIATRIE, 2004, 11 (01): : 74 - 77
  • [38] Identifying Raynaud's phenomenon
    Blin, Aurore
    ACTUALITES PHARMACEUTIQUES, 2019, 58 (591): : 42 - 45
  • [39] Primary Raynaud's Phenomenon
    Alweis, Eliana A.
    Alweis, Richard L.
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2025, 15 (01):
  • [40] Raynaud's phenomenon in children
    Ortega Vicente, Elena
    Garrido Redondo, Mercedes
    REUMATOLOGIA CLINICA, 2016, 12 (06): : 342 - 344
12345